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Introduction
The highly related proteins of the Ena/VASP family – Mena, VASP
and EVL – play pivotal roles in cell movement and shape change
in vertebrates. Ena/VASP proteins are active in various cell types,
including fibroblasts (Bear et al., 2000), endothelial cells (Furman
et al., 2007), epithelial cells (Gates et al., 2007; Lawrence et al.,
2002; Vasioukhin et al., 2000) and neurons (Lanier et al., 1999;
Lebrand et al., 2004; Kwiatkowski et al., 2007); Ena/VASP proteins
directly regulate assembly of the actin-filament network, modulate
the morphology and behavior of membrane protrusions such as
filopodia and lamellipodia (see below), and influence cell motility
(Bear et al., 2002; Gertler et al., 1996; Lacayo et al., 2007). VASP
also plays an important role in modulating ‘inside out’ agonist-
induced integrin activation in platelets (Aszodi et al., 1999;
Massberg et al., 2004; Hauser et al., 1999).
Caenorhabditis elegans and Drosophila melanogaster each
contain a single Ena/VASP ortholog (Krause et al., 2003); genetic
analysis in these systems and in mice revealed roles for Ena/VASP
in axon guidance. In mice, genetic studies reveal that Ena/
VASP proteins also have crucial roles in neuritogenesis and
endothelial barrier formation and neural-tube closure (Furman
et al., 2007; Kwiatkowski et al., 2007; Lanier et al., 1999;
Menzies et al., 2004). Ena/VASP family members are concentrated
at focal adhesions, the distal rim of the lamellipodium and the tips
of filopodia in migratory cells (Fig. 1). Therefore, this protein family
is perfectly positioned to serve a role in the early rearrangement of
the actin cytoskeleton in response to migration cues.
Although there is considerable evidence that Ena/VASP proteins
act as actin anti-capping proteins (see below), some controversy
remains over their mechanism of action. In this Commentary, we
evaluate the evidence for and against the anti-capping hypothesis,
including results from several recent structural and biochemical
studies that shed new light on this issue. In addition, we describe
several alternate mechanisms that Ena/VASP proteins may utilize
to regulate actin dynamics in vivo, including inhibition of branching,
bundling and profilin-actin recruitment.
A primer on the actin cytoskeleton
To set the stage for our discussion of Ena/VASP function, we will
provide a simplified overview of the aspects of actin dynamics and
some actin-regulatory proteins that are relevant to this Commentary.
For a comprehensive treatment of actin dynamics, we refer the
reader to two of many excellent reviews on this topic (Chhabra and
Higgs, 2007; Pollard and Borisy, 2003).
Actin assembly can drive formation of membrane protrusions
such as lamellipodia (which are wide, flat structures containing
dense, branched F-actin networks) or filopodia (which are thin
cylindrical protrusions comprising bundled, parallel F-actin
filaments). The morphology and dynamics of membrane protrusions
can be altered by regulation of the length of actin filaments, and
of their stability, density and organization (Lacayo et al., 2007;
Mogilner, 2006). Regulated actin-filament elongation, branching,
bundling, severing and capping help to create the actin network
within protrusions (Chhabra and Higgs, 2007; Pollard and Borisy,
2003).
Polymerization of growing actin filament ‘barbed’ ends is thought
to drive membrane protrusion (Mogilner and Oster, 2003).
Spontaneous F-actin assembly is suppressed within cells by proteins
that sequester actin monomers; therefore, the generation of barbed
ends requires proteins that nucleate new filaments, or that sever or
uncap filaments whose growth has been terminated by actin-
filament-capping proteins (Pollard and Borisy, 2003). The Arp2/3
complex nucleates new filaments that branch off from the sides of
existing filaments (Blanchoin et al., 2000; May et al., 1999; Mullins
et al., 1998), preferentially near their barbed ends (Ichetovkin et
al., 2002). Arp2/3-mediated nucleation contributes in part to the
dense array of branched F-actin networks within the lamellipodium
(Bailly et al., 1999; Svitkina and Borisy, 1999); regulated activation
of Arp2/3 at the plasma membrane causes nucleation of filaments
that elongate transiently (until they are capped), driving
lamellipodial protrusion (Pollard and Borisy, 2003). Filopodia arise
from lamellipodia, and actin within filopodia is shaped into parallel
bundles by the F-actin-bundling protein fascin. The filaments that
become bundled by fascin can arise by several mechanisms,
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including elongation of Arp2/3-nucleated filament or de novo
assembly by a different class of actin-nucleating proteins, the
formins (Gupton and Gertler, 2007). Formins nucleate linear actin
filaments and remain attached to the polymerizing filaments,
protecting them from being capped (Chhabra and Higgs, 2007).
Interestingly, protrusive forces produced by Arp2/3-nucleated
actin-filament networks also drive the movement of a number of
intracellular pathogens, including Listeria monocytogenes
(Lambrechts et al., 2008). Listeria co-opt elements of the host-cell
cytoskeleton by expressing a protein (ActA) on their surface that
contains motifs that bind Arp2/3, actin and Ena/VASP, effectively
mimicking several cellular actin-regulatory proteins. ActA activates
Arp2/3, causing actin to polymerize on the bacterial surface.
Listeria propulsion requires several other proteins that do not bind
directly to the bacterium, two of which are germane here – capping
protein (CP) and profilin. CP is a barbed-end capping protein and
is thought to increase the rate of Listeria motility by enhancing
Arp2/3 nucleation (Akin and Mullins, 2008). By capping
polymerizing filaments near the bacterium, CP increases the pool
of actin monomer that is available for Arp2/3 nucleation. Profilin
is an abundant actin-monomer-binding protein that functions to
promote formation of ATP-actin monomer by nucleotide exchange.
When bound to profilin, actin cannot spontaneously nucleate and
can only be added on to the barbed end of growing filaments. Thus,
profilin provides a pool of polymerization-competent actin monomer
for barbed-end elongation. In addition to binding to actin, profilin
binds to proteins that contain a specific polyproline-rich motif
(Ferron et al., 2007) that is found in a number of actin-regulatory
proteins including Ena/VASP (discussed below). Ena/VASP proteins
are not essential for Listeria motility, but stimulate bacterial velocity
and enable Listeria to spread from cell to cell. Several mechanisms
for Ena/VASP stimulation of Listeria have been proposed, including
recruitment of profilin-actin to the bacterium and interactions with
the F-actin tail.
Domain structure and interactions of Ena/VASP
proteins
Ena/VASP proteins contain several specific domains that are shared
in all family members (Krause et al., 2003) (Fig. 2); these include
the N-terminal Ena/VASP homology 1 (EVH1) domain, the proline-
rich domain and the C-terminal EVH2 domain. The EVH1 domain
binds to a specific proline-rich motif. Functional EVH1-binding sites
are found in a number of proteins, including lamellipodin, the axon-
guidance receptor Robo and the focal-adhesion proteins zyxin and
vinculin. The proline-rich domain, in the middle portion of
Ena/VASP proteins, binds to SH3- and WW-domain-containing
proteins, and also to profilin. The EVH2 domain binds to G- and
F-actin and mediates the tetramerization of Ena/VASP. EVH2-
mediated interactions with growing ends of actin filaments are
required for efficient targeting of Ena/VASP proteins to lamellipodia
and filopodia.
Ena/VASP binds to profilin–G-actin complexes through two
interfaces simultaneously, a profilin:Ena/VASP interface and a
G-actin:Ena/VASP interface. The G-actin in the profilin–G-
actin–Ena/VASP complex is oriented towards the F-actin binding
motif of Ena/VASP; it is presumably positioned in this way to
facilitate its addition to growing filaments (Ferron et al., 2007). The
G-actin binding motif in Ena/VASP also stabilizes it at the tips of
filopodia (Applewhite et al., 2007). Vertebrate Ena/VASP proteins
are in vivo substrates for the cyclic-nucleotide-dependent kinases
PKA and PKG; phosphorylation at sites within the EVH2 domain
reduces binding of Ena/VASP to G- and F-actin and negatively
regulates Ena/VASP function in lamellipodia (Barzik et al., 2005;
Harbeck et al., 2000; Lindsay et al., 2007).
The anti-capping hypothesis of Ena/VASP function
Ena/VASP proteins have been proposed to act as actin anti-capping
proteins. The general idea of anti-capping by Ena/VASP proteins
is that the proteins permit actin-filament elongation, even in the
presence of high levels of capping proteins. This activity is
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Fig. 1. Intracellular distribution of Ena/VASP proteins. Immunofluorescence
staining for VASP (green) and F-actin (red) in a fibroblast.
(D/E)FPPPPX(D/E)(D/E) Profilin G- and F-
actin
Tetramerization
GAB FAB Coiled coil
Fig. 2. Domain structure of Ena/VASP
proteins. The EVH1 and EVH2 domains
and proline-rich region are indicated. EVH1
mediates protein:protein interactions; most,
but not all, EVH1 ligands bind to a motif
that has the consensus sequence
(D/E)FPPPPX(D/E)(D/E). The proline-rich
region harbors binding sites for profilin,
including a high-affinity site adjacent to the
EVH2 domain. The EVH2 domain contains
a G-actin-binding site (GAB), an F-actin-
binding site (FAB) and a coiled-coil at the













necessary to allow the formation of the long filaments within cells
that contribute to structures such as filopodia. In fact, many cell
types, particularly neurons, require Ena/VASP function for
filopodium formation (Dent et al., 2007; Lebrand et al., 2004).
Ena/VASP supports filopodium formation by antagonizing actin-
filament capping activity (Barzik et al., 2005; Bear et al., 2002)
and by promoting clustering of filaments at their polymerizing ends
(Applewhite et al., 2007).
However, there is considerable controversy in this field, some
of which arises from confusion over the definition of anti-capping
activity. The anti-capping hypothesis of Ena/VASP function
specifically states that Ena/VASP proteins associate with elongating
actin filaments at or near their rapidly growing (barbed) end in such
a way as to block the action of capping proteins that terminate
elongation (Fig. 3). It is important to note that this hypothesis does
not state that Ena/VASP proteins can remove capping proteins that
have become stably associated with filaments (uncapping) nor does
it state that Ena/VASP proteins have any effect on the
depolymerization of actin filaments from their barbed end (weak
capping) nor that Ena/VASP associates processively with the
growing actin filaments. One final point about this hypothesis is
that anti-capping is not mutually exclusive with other established
Ena/VASP functions such as filament clustering, bundling or anti-
branching (discussed below).
The anti-capping hypothesis was developed on the basis of results
that were obtained by manipulating Ena/VASP activity in fibroblasts
(Bear et al., 2002), but it also draws on earlier work about the
biochemical function of CP in neutrophil lysates (DiNubile et al.,
1995). In the fibroblast system, genetic deletion or sequestration of
Ena/VASP proteins led to faster cell motility with more persistent
lamellipodial protrusions (Bear et al., 2002). The actin filaments
within these lamellipodia were shorter and more highly branched,
suggesting that filament capping activity was increased. Conversely,
membrane targeting of Ena/VASP protein led to longer filaments
with fewer branches. Collectively, these data suggested that
Ena/VASP proteins were ‘anti-capping’ factors. In the mid-1990s,
Zigmond and colleagues, using neutrophil extracts and
permeabilized cells, demonstrated the existence of factors that
compete with CP and maintain a pool of extending barbed ends
(DiNubile et al., 1995). Although the molecular identity of this factor
or factors was not established, the fact that such an activity existed
implied that the proposed anti-capping activity of Ena/VASP
proteins was plausible.
Further evidence supporting the anti-capping
hypothesis
In addition to the data described above, several types of evidence
support the anti-capping model for Ena/VASP function, including
in vitro assays with purified proteins, structural analysis, cell
biological experiments and genetics.
Ena/VASP anti-capping activity has been observed indirectly
in pyrene actin polymerization assays (Bear et al., 2002; Barzik
et al., 2005) and directly in total internal reflection fluorescence
microscopy (TIRF) assays (Pasic et al., 2008) (see Box 1 for more
details on these assays). Purified VASP delayed termination of
filament growth by heterodimeric CP. The filament elongation rate
was enhanced by addition of profilin along with VASP. These data
support earlier kinetic experiments in which spectrin–F-actin
seeded (‘SAS’) pyrene-actin polymerization assays were used to
test for the antagonism of capping proteins by VASP (Barzik et al.,
2005; Bear et al., 2002). VASP increased F-actin polymerization
in SAS assays in the presence of CP, an effect that was enhanced
by profilin. VASP anti-capping activity was also observed when
a CapG, a capping protein unrelated to CP, was used in the assay.
The kinetic experiments also demonstrated that the stimulatory
effect of profilin on VASP anti-capping required direct
profilin:VASP and profilin:G-actin interactions (Barzik et al.,
2005; Bear et al., 2002). Importantly, all of these kinetic and visual
assays were done under conditions in which VASP exhibited
negligible nucleation activity.
Fig. 3. Mechanism of anti-capping by Ena/VASP proteins.
(A) Tetramer of VASP in association with a bundle of actin
filaments. Interactions between the EVH1 domain of Ena/VASP
and FPPPP-motif-containing proteins help to position the
Ena/VASP tetramer near the plasma membrane. (B) The
profilin–G-actin loading mechanism by which Ena/VASP is
thought to supply actin monomers to the barbed ends of













The ability of Ena/VASP to interact with barbed ends was
demonstrated directly using TIRF microscopy (Pasic et al., 2008).
In these experiments, VASP was immobilized on a coverslip and
preformed, labeled actin filaments were flowed in under conditions
that permitted the elongation of barbed, but not pointed, ends. The
immobilized VASP captured filament barbed ends; importantly,
filaments pre-capped with a barbed-end CP were not captured. These
results were consistent with earlier studies indicating that VASP
immobilized on beads could capture F-actin with free barbed ends,
but not F-actin that had been capped by CP (Bear et al., 2002).
Interestingly, barbed-end capture requires only the very C-terminal
part of the EVH2 domain, CT (Pasic et al., 2008), a region that
lacks the known actin-binding motifs (Bachmann et al., 1999;
Harbeck et al., 2000). The CT sequence contains a coiled-coil that
tetramerizes in parallel with an unusual right-handed coil (Kuhnel
et al., 2004), raising the interesting possibility that this forms a
structural interface for binding to barbed ends of F-actin (which
also forms a right-handed coil).
The anti-capping activity of Ena/VASP proteins was recently
confirmed by the Faix group (Breitsprecher et al., 2008). In these
studies, VASP immobilized on beads was capable of supporting
continuous elongation of filaments even in the presence of a very
high concentration of CP. This arrangement is likely to be similar
to physiological situations in which Ena/VASP proteins are tethered
at specific locations by interactions with the EVH1 domain and
FPPPP-containing ligands. This study did not find anti-capping
activity for VASP when it was in solution, as others have; however,
this may be due to differences in specific assay conditions or protein
preparation or storage conditions (see below).
Several types of cell-biological evidence support the hypothesis
that Ena/VASP proteins interact with F-actin barbed ends. In some
cell types, including endothelial cells, Ena/VASP localizes in a
sarcomeric pattern along stress fibers (Furman et al., 2007;
Reinhard et al., 1992). Barbed-end labeling of permeabilized
endothelial cells with labeled actin monomer revealed that
monomers were inserted into stress fibers adjacent to VASP,
reflecting close proximity of VASP to free barbed ends (Furman
et al., 2007). In experiments in which Ena/VASP function was
blocked, there was a dramatic reduction in the amount of F-actin
in stress fibers and in the amount of monomer incorporated into
barbed ends. Other data supporting Ena/VASP–barbed-end
interactions involve treatment of cells with nanomolar
concentrations of cytochalasin D, a drug that blocks barbed ends
and displaces Ena/VASP from the tips of protruding lamellipodia
in several cell types, including fibroblasts (Bear et al., 2002), MCF7
cells (Scott et al., 2006), B16 melanoma cells (Krause et al., 2004)
and keratocytes (Lacayo et al., 2007), indicating that growing
barbed ends are required for proper Ena/VASP localization within
lamellipodia. Experimental increases or decreases in levels of
Ena/VASP in keratocytes resulted in changes in lamellipodial
morphology that were consistent with a mathematical model in
which Ena/VASP exhibited anti-capping activity (Lacayo et al.,
2007). Finally, fluorescence recovery after photobleaching (FRAP)
experiments revealed that VASP is stably associated with growing
filaments in filopodial tips (Applewhite et al., 2007): co-FRAP of
VASP and actin revealed rapid recovery of actin with no recovery
of VASP signal, indicating that there is little or no turnover in the
VASP pool within the filopodial tip, whereas new actin monomers
are continually incorporated at the tip.
Unresolved issues regarding the anti-capping
hypothesis
Although most recent studies support the anti-capping hypothesis,
there remain a few unresolved issues regarding this idea. For
example, early data from one group indicated that VASP had no
effect on actin polymerization in the presence of the barbed-end
capping protein gelsolin (Boujemaa-Paterski et al., 2001). The
authors concluded that VASP did not affect the ability of capping
proteins to function. It is worth noting that these reactions also
contained ActA and Arp2/3, whose presence would lead to a
complex set of nucleation and elongation reactions that may have
complicated the interpretation of this experiment. These studies may
need to be revisited with techniques such as time-lapse TIRF to
understand the effect of VASP in these reactions.
Another issue that remains unresolved is the effect of Ena/VASP
proteins on filament elongation, with and without profilin. Some
studies have found no effect of VASP alone on filament elongation
rates (Barzik et al., 2005; Bear et al., 2002), whereas another finds
a significant increase in elongation in the presence of VASP
(Breitsprecher et al., 2008). These studies also reached the opposite
conclusion about the role of profilin in VASP activity. In one study,
profilin increased barbed-end elongation in the presence of VASP
(Barzik et al., 2005), whereas the other saw no effect (Breitsprecher
et al., 2008). It is unclear why these experiments led to different
results, but these discrepancies may reflect differences in how the
recombinant VASP was prepared, stored or immobilized on beads;
VASP anti-capping activity is quite sensitive to storage conditions
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Box 1. In vitro techniques for measuring Ena/VASP
function
Pyrene actin polymerization assay
In this assay, actin polymerization is measured by the increase in
fluorescence in a bulk format such as a cuvette. The fluorescence
in this assay arises from the dye, pyrene, which is covalently
coupled to a fraction (usually 5-10%) of the total actin in the
assay. Upon incorporation of these pyrene-labeled actin
monomers into filaments, the fluorescence increases. This assay
yields remarkably detailed kinetic information about the extent of
total polymerization, but does not give information about the
length or architecture of the actin filaments that are formed. In
some instances, these reactions are ‘jump-started’ by adding
actin filament seeds in the form of spectrin–F-actin seeds (SAS).
Microscopy-based visual assays
In this assay, actin polymerization is monitored directly by
observing the formation of individual filaments with TIRF. As in
the bulk pyrene assay, a fraction of the actin is labeled with a
fluorescent dye in the visible range such as Oregon Green 488
(Molecular Probes). A simpler version of this assay involves
stopping diluted polymerization reactions with fluorescent
phalloidin (a molecule that binds to the sides of actin filaments
and prevents depolymerization) and observing the reaction with
TIRF or traditional epifluorescence microscopy.
Reconstituted motility assays
Another assay that is used to probe the role of actin-binding
proteins such as Ena/VASP proteins is the in vitro reconstitution
assay. In this assay, beads coated with actin nucleators such as
ActA are added to complex mixtures of purified proteins or
lysates obtained from cells or tissues that contain all the
necessary factors to support the motility of the beads. Information
about the percentage of motile beads and their motility
characteristics such as speed are determined by observing the












(Melanie Barzik, Laboratory of Cell Biology, NHLBI, NIH,
Bethesda, MD; personal communication).
Other possible mechanisms of Ena/VASP function
In addition to their proposed anti-capping activity, Ena/VASP
proteins have other biochemical activities that may operate in
parallel with, or synergistically with, anti-capping to modulate actin
dynamics in vivo.
Anti-branching
Several groups have noted that Ena/VASP proteins reduce the
frequency of actin-filament branching by the Arp2/3 complex
(Bear et al., 2002; Plastino et al., 2004; Samarin et al., 2003;
Skoble et al., 2001). The strongest evidence for a direct anti-
branching effect comes from the work of Skoble and colleagues
(Skoble et al., 2001). They observed that VASP reduced the
branching induced by ActA-activated Arp2/3 complex in visual
assays. These reactions did not contain capping proteins and the
observed anti-branching activity must be independent of its anti-
capping function. The mechanism of this direct effect on branching
remains unknown, although it is tempting to speculate that
Ena/VASP proteins compete with the Arp2/3 complex for actin
monomers, which are necessary cofactors for branching.
Alternatively, Ena/VASP proteins might act directly to inhibit
branching; for instance, they might prevent the docking of the
Arp2/3 complex onto the side of a mother actin filament.
Another possible explanation for the observed anti-branching
activity of Ena/VASP proteins is through an indirect effect on CP.
Akin and Mullins recently described a striking mechanism for
controlling the frequency of Arp2/3 branching through the capping
of barbed ends (Akin and Mullins, 2008). They demonstrated that
increasing capping activity actually increases branching because the
levels of actin monomers are locally elevated. Anti-capping factors
such as Ena/VASP proteins would therefore be predicted to decrease
branching by the reduction of barbed-end capping, which would lead
to the increased consumption of monomers through their addition
to barbed ends. It has also been proposed that Ena/VASP exerts a
catalytic debranching effect on Arp2/3 branches (Plastino et al., 2004;
Samarin et al., 2003); however, this idea needs to be confirmed with
more direct assays such as TIRF. Future experiments will be
required to delineate the precise role of Ena/VASP in Arp2/3 branch
dynamics.
Bundling
Ena/VASP proteins bundle actin filaments; this property was
identified soon after their discovery and might contribute to the
mechanism of anti-capping (Bachmann et al., 1999). Bundling
requires both the F-actin-binding activity of Ena/VASP proteins and
their tetramerization (both of these activities are mediated by the
EVH2 domain) (Fig. 2). The formation of bundles is sensitive to
the concentration of salt, which suggests that electrostatic
interactions between Ena/VASP proteins and actin filaments
contribute to bundling (Barzik et al., 2005). In contrast to other
bundling proteins, such as fascin, Ena/VASP proteins are not found
along the entire length of actin bundles in vivo. In filopodia, for
example, Ena/VASP proteins are restricted to the distal tips of
bundles (Lanier et al., 1999). This stable, restricted localization
requires the G-actin-binding site of Ena/VASP proteins and probably
reflects the interaction between oligomers of Ena/VASP and the
barbed ends of actin filaments in the filopodial bundle (Applewhite
et al., 2007).
Nucleation
Another biochemical property of Ena/VASP proteins is their ability
to nucleate actin filaments in vitro; however, the significance of
this effect in vivo remains unclear. Actin-filament nucleation by
various Ena/VASP isoforms has been noted by multiple groups using
the pyrene actin polymerization assay (Huttelmaier et al., 1999;
Lambrechts et al., 2000; Skoble et al., 2001). This nucleation is
highly dependent on the salt concentration in the reaction and mainly
occurs at sub-physiological salt concentrations. As noted above,
this in vitro nucleation effect often complicates the interpretation
of pyrene actin polymerization experiments involving VASP. In
vivo, Ena/VASP proteins are unlikely to be physiological actin
nucleators: mitochondrial targeting of Ena/VASP reveals no
accumulation of F-actin (Bear et al., 2000). Similarly, Listeria
expressing an ActA mutant protein that recruits Ena/VASP but not
Arp2/3 fails to accumulate any detectable F-actin (Lasa et al., 1995;
Pistor et al., 2000).
Profilin recruitment
Recent structural and biochemical analyses indicate that VASP
harbors a high-affinity profilin-binding ‘actin-loading site’ adjacent
to its actin-monomer-binding motif (Chereau and Dominguez, 2006;
Ferron et al., 2007). The affinity of profilin–G-actin complexes for
the VASP loading site is 7.5 μM, about tenfold higher than that of
profilin alone. Interestingly, the presence of the actin-loading site
on VASP also doubled the affinity of profilin for G-actin. The
structural studies suggest a model in which profilin–G-actin binds
to the Ena/VASP loading site in a manner that allows the actin
monomer to bind to the Ena/VASP G-actin binding site (which is
adjacent to the F-actin-binding motif). Such a model would explain
how actin monomers could be transferred efficiently from profilin
to the barbed ends of actin filaments while bound to Ena/VASP;
elements of this model are similar to those proposed for VASP
function in Listeria motility over 10 years ago (Purich and
Southwick, 1997; Smith et al., 1996). The model is consistent with
the ability of profilin to increase Ena/VASP anti-capping activity
by increasing filament-elongation rates (Barzik et al., 2005); it is
important to note, however, that profilin is not required for VASP
anti-capping activity.
Augmenting formin function
Experiments in Dictyostelium indicate that the orthologs of the
formin mDia2 and VASP are both required for filopodium
formation: deletion of either gene ablates filopodium formation
(Schirenbeck et al., 2006). Further experiments indicated that the
F-actin binding site in Dictyostelium VASP was required for it to
support the formation of filopodia. Together, these results, along
with in vitro data on actin bundling, led Schirenbeck and coworkers
to propose that the sole function of VASP in filopodium formation
in Dictyostelium was to bundle filaments that were nucleated and/or
elongated by the activity of Dia2. As the anti-capping activity of
VASP requires its ability to bind to F-actin, the aforementioned
experiments do not distinguish between a role for VASP in bundling,
anti-capping or both. Work in mammalian cells indicates that
filament bundling and anti-capping by Ena/VASP both contribute
to filopodium formation (Applewhite et al., 2007); Ena/VASP is
likely both to protect filaments from capping and to cause them to
cluster at their growing barbed ends, after which fascin bundles
them along their length (Svitkina et al., 2003; Vignjevic et al., 2003).
Additionally, the Dictyostelium results are not transferable to












can form filopodia independently of one another. In particular, in
neurons that are genetically deficient in all three Ena/VASP proteins
and lack filopodia (Dent et al., 2007), filopodium formation can be
rescued by expression of mDia2. It is, however, possible that other
formin family members have a role in filopodium formation in
conjunction with Ena/VASP. Recent work in Drosophila suggests
that the formin subfamily member DAAM is localized along
filopodia and shows some overlap with Ena at the filopodial tip
(Matusek et al., 2008). Further experiments will be required to
dissect the functional interactions between Ena/VASP and formin
proteins in mammalian systems.
Conclusions and perspectives
On the basis of the current published literature, the anti-capping
model of Ena/VASP function seems to be the simplest explanation
for many of the known cell-biological and biochemical properties
of this protein family. By extension, anti-capping could also account
for the demonstrable ability of Ena/VASP to reduce the branching
density of filaments; it might do this by maintaining free barbed
actin-filament ends that would compete with Arp2/3 for actin-
monomer binding. A clearer understanding of how Ena/VASP
functions to promote the formation of longer, less-branched
networks will require structural information showing exactly how
Ena/VASP interacts with F-actin. Furthermore, visual assays with
Arp2/3 will help clarify how Ena/VASP exerts its anti-branching
activity. Finally, the mechanism underlying the ability of VASP (and
probably Mena and EVL) to modulate integrin activation is poorly
understood; it is unclear whether the effects of Ena/VASP proteins
on adhesion are linked to anti-capping or represent a distinct
molecular activity. Resolving these and other outstanding questions
about Ena/VASP function will allow a greater insight into actin-
based motility and the physiological processes that depend on
precisely controlled actin dynamics.
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Commentaries and Cell Science at a Glance
JCS Commentaries highlight and critically discuss recent and exciting findings that will interest those who work in cell biology, molecular
biology, genetics and related disciplines, whereas Cell Science at a Glance poster articles are short primers that act as an introduction to
an area of cell biology, and include a large poster and accompanying text. 
Both of these article types, designed to appeal to specialists and nonspecialists alike, are commissioned from leading figures in the field
and are subject to rigorous peer-review and in-house editorial appraisal. Each issue of the journal usually contains at least one of each
article type. JCS thus provides readers with more than 50 topical pieces each year, which cover the complete spectrum of cell science.
The following are just some of the areas that will be covered in JCS over the coming months:
Cell Science at a Glance
WASP and SCAR/WAVE proteins – the drivers of actin assembly Robert Insall
The ESCRT machinery at a glance Jim Hurley
DUBs at a glance Keith Wilkinson
Podosomes and invadopodia at a glance Stefan Linder
Collective cell migration at a glance Peter Friedl
Establishment and maintenance of DNA methylation patterns Tim Bestor
mTOR signalling at a glance David Sabatini
Commentaries
How do ESCRT proteins control autophagy? Harald Stenmark
How do anti-mitotic drugs kill cancer cells? Stephen Taylor
How peroxisomes multiply Ewald Hettema
An update on nuclear calcium signalling Martin Bootman
Mechanisms for transcellular diapedesis Chris Carman
The Crumbs complex Elisabeth Knust 
ABL-family kinases Tony Koleske
Tail-anchored protein biogenesis – the beginning for the end? Stephen High
Although we discourage the submission of unsolicited Commentaries and Cell Science at a Glance poster articles to the journal, ideas
for future articles – in the form of a short proposal and some key references – are welcome and should be sent by email to the Editorial
Office (jcs@biologists.com).
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